KORU Medical Systems, Inc. financial data

Symbol
KRMD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
100 Corporate Drive, Mahwah, NJ
State of incorporation
New York
Fiscal year end
December 31
Former names
REPRO MED SYSTEMS INC (to 6/3/2022)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 433 % -13.2%
Quick Ratio 74.4 % -35.8%
Debt-to-equity 38.6 % +25.1%
Return On Equity -54.9 % -106%
Return On Assets -39.7 % -94.7%
Operating Margin -23.2 % +33.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.9M shares +0.47%
Common Stock, Shares, Outstanding 45.8M shares +0.45%
Entity Public Float 111M USD +54.7%
Common Stock, Value, Issued 492K USD +0.42%
Weighted Average Number of Shares Outstanding, Basic 45.8M shares +0.45%
Weighted Average Number of Shares Outstanding, Diluted 45.8M shares +0.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 30.8M USD +4.7%
Research and Development Expense 5.19M USD -8.38%
Operating Income (Loss) -7.14M USD +30.8%
Nonoperating Income (Expense) 528K USD +60.1%
Income Tax Expense (Benefit) 3.97M USD
Net Income (Loss) Attributable to Parent -11.8M USD -45%
Earnings Per Share, Basic -0.26 USD/shares -62.5%
Earnings Per Share, Diluted -0.26 USD/shares -62.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.5M USD -10.8%
Accounts Receivable, after Allowance for Credit Loss, Current 5.85M USD +60.6%
Inventory, Net 2.59M USD -51%
Assets, Current 19.4M USD -14.1%
Deferred Income Tax Assets, Net 5.45M USD +54.7%
Property, Plant and Equipment, Net 3.68M USD -3.49%
Operating Lease, Right-of-Use Asset 3.41M USD -5.83%
Other Assets, Noncurrent 99K USD 0%
Assets 27.3M USD -24.1%
Accounts Payable, Current 1.6M USD +1.34%
Employee-related Liabilities, Current 444K USD +5.12%
Accrued Liabilities, Current 2.14M USD +57.4%
Liabilities, Current 5.14M USD +26%
Operating Lease, Liability, Noncurrent 3.2M USD -7.84%
Liabilities 8.6M USD +8.92%
Retained Earnings (Accumulated Deficit) -26.2M USD -81.2%
Stockholders' Equity Attributable to Parent 18.7M USD -33.4%
Liabilities and Equity 27.3M USD -24.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -347K USD +92.6%
Net Cash Provided by (Used in) Financing Activities -182K USD +23.8%
Net Cash Provided by (Used in) Investing Activities -133K USD +53.1%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 49.3M shares +0.46%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -662K USD +87.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.3K USD -0.24%
Deferred Tax Assets, Valuation Allowance 6.58M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Operating Lease, Liability 3.59M USD -6.1%
Depreciation 218K USD +2.32%
Lessee, Operating Lease, Liability, to be Paid 2.83M USD +2007%
Property, Plant and Equipment, Gross 6.81M USD +9.33%
Operating Lease, Liability, Current 392K USD +11%
Lessee, Operating Lease, Liability, to be Paid, Year Two 534K USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 267K USD +6.9%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Three 534K USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 534K USD +6.9%
Operating Lease, Payments 120K USD +5.76%
Depreciation, Depletion and Amortization 894K USD +14.9%
Deferred Tax Assets, Net of Valuation Allowance 3.97M USD +104%